Director: Adrian Harris
Our clinical research programme includes phase II and III trials and phase I studies of novel agents. Each consultant medical oncologist specialises in a subset of tumours which include breast, lung and gynaecological cancers. Our principal research interests are in angiogenesis, drug resistance and novel cytotoxics, gene and immunotherapy and oncogene signalling pathways.
Mailing address:
The Weatherall Institute of Molecular Medicine
University of Oxford
John Radcliffe Hospital
Headington
Oxford
OX3 9DS |
